Bibliografia

1. Plassat R, Perrouin Verbe B, Menei P, et al. Treatment of spasticity with intrathecal Baclofen administration: long-term follow-up, review of 40 patients. Spinal Cord 2004; 42: 686-93.
2. Kroin J , Ali A, York M, Penn RD. The distribution of medication along the spinal canal after chronic intrathecal administration. Neurosurgery 1993; 33: 226-30.
3. Penn RD, Savoy SM, Corcos D, et al. “Intrathecal baclofen for severe spinal spasticity”. N Engl J Med 1989; 320: 1517-21.
4. AL Albright, R Gilmartin et al. Long-term intrathecal baclofen therapy for severe spasticity of cerebral origin. J Neurosurg 2003; 98: 291-5.
5. Zahavi A, Geertzen JB, Middel B, et al. Long term effect (more than five years) of intrathecal baclofen on impairment, disability, and quality of life in patients with severe spasticity of spinal origin. J Neurol Neurosurg Psychiatry 2004; 75: 1553-7.
6. Coffey RJ, Cahill DC, Steers W, et al. Intrathecal baclofen for intractable spasticity of spinal origin: results of a long-term multicenter study. J Neurosurg 1993; 78: 226-32.
7. Becker R, Alberti O, Bauer BL. Continuous intrathecal baclofen infusion alleviates autonomic dysfunction in patients with severe supraspinal spasticity. J Neurosurg Psychiatry 1999; 66: 114-5.
8. Francisco GE, Hu MM, Boake C, Ivanhoe CB. Efficacy of early use of intrathecal baclofen therapy for treating spastic hypertonia due to acquired brain injury. Brain Inj 2005; 19 (5): 359-64.
9. Becker R, Alberti O, Bauer BL. Continuous intrathecal baclofen infusion in severe spasticity after traumatic or hypoxic injury. J Neurol 1997; 244: 160-6.